About
Restoring neuronal function with drugs that specifically stimulate the neuronal microtubules
Areas of Focus
Categories
Small Molecule Pharmaceutical
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
1
As Collaborator
1
Total Enrollment
110
By Phase
PHASE2: 2
By Status
WITHDRAWN: 1ACTIVE_NOT_RECRUITING: 1
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details
Recent Trials
NCT04157114Collaborator
MAP4343 Treatment for Alcohol Use Disorder
PHASE2Withdrawn
Started: Dec 31, 2021 · Completed: Dec 31, 2022
NCT03870776Lead Sponsor
RESIST : Administration of MAP4343 in Antidepressant Non-Responders Patients Experiencing a Major Depressive Episode
PHASE2Active, not recruiting
110 participants
Started: Jun 1, 2019 · Completed: Mar 1, 2025
Locations (1)
Headquarters
Paris, France
Map
Loading map...